tiprankstipranks
Giant Biogene Holding Co. Ltd. (HK:2367)
HKEX:2367
Hong Kong Market
Holding HK:2367?
Track your performance easily

Giant Biogene Holding Co. Ltd. (2367) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

2367 Analyst Ratings

Strong Buy
3Ratings
3 Buy
0 Hold
0 Sell
Based on 3 analysts giving stock ratings to
Giant
Biogene Holding Co. Ltd.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

2367 Stock 12 Month Forecast

Average Price Target

HK$70.07
▲(34.75% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for Giant Biogene Holding Co. Ltd. in the last 3 months. The average price target is HK$70.07 with a high forecast of HK$80.00 and a low forecast of HK$65.00. The average price target represents a 34.75% change from the last price of HK$52.00.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"29":"HK$29","42":"HK$42","55":"HK$55","68":"HK$68","81":"HK$81"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":80,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$80.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":70.07,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$70.07</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":65,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$65.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[29,42,55,68,81],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2023","6":"Jun<br/>2024","9":"Sep<br/>2024","12":"Dec<br/>2024","25":"Dec<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,51.3,53.5076923076923,55.715384615384615,57.92307692307692,60.13076923076923,62.33846153846154,64.54615384615384,66.75384615384615,68.96153846153845,71.16923076923077,73.37692307692308,75.58461538461538,77.79230769230769,{"y":80,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,51.3,52.74384615384615,54.1876923076923,55.631538461538454,57.075384615384614,58.51923076923077,59.96307692307692,61.40692307692307,62.850769230769224,64.29461538461538,65.73846153846154,67.18230769230769,68.62615384615384,{"y":70.07,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,51.3,52.35384615384615,53.40769230769231,54.46153846153846,55.51538461538461,56.56923076923077,57.62307692307692,58.676923076923075,59.730769230769226,60.784615384615385,61.83846153846154,62.892307692307696,63.94615384615385,{"y":65,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":33.26,"date":1696118400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":32.97,"date":1698796800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":34.93,"date":1701388800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":31.2,"date":1702598400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.66,"date":1704412800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.62,"date":1706832000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.85,"date":1719532800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.75,"date":1720137600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.55,"date":1722556800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.6,"date":1725580800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":56.85,"date":1728000000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.6,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51.3,"date":1733443200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetHK$80.00Average Price TargetHK$70.07Lowest Price TargetHK$65.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Macquarie
HK$55
Buy
5.77%
Upside
Initiated
09/04/24
Macquarie Starts Giant Biogene Holding Co (2367:HK) at OutperformMacquarie analyst Sunny Chow initiates coverage on Giant Biogene Holding Co (2367:HK) with a Outperform rating and a price target of HK$55.00.
CMB International Securities
HK$62.07
Buy
19.37%
Upside
Reiterated
08/21/24
We expect to generate revenue of over RMB100mn in 2024E. Furthermore, the Company is actively expanding Comfy brand to offline sales channels. Revenue from medical dressing products rallied 49% 1H24 thanks to its increasing presence in pharmacies and introduction of new medical dressing products.  Collgene brand gradually unleashed its potential. While experiencing a decline in revenue from Xi’an Chuangkecun, it was largely compensated by a surge in online sales. During the 618 Shopping Festival of 2024, the GMV of Collgene brand increased over 100% YoY, contributing to a 23.6% YoY increase in revenue, totalling RMB396mn in 1H24.
Citi
Buy
Initiated
06/27/24
Giant Biogene Holding Co. Ltd. (2367) Gets a Buy from Citi
Goldman Sachs Analyst forecast on HK:2367
Unknown Analyst
Not Ranked
Goldman Sachs
HK$48HK$55
Buy
5.77%
Upside
Reiterated
05/06/24
Giant Biogene Holding Co (2367:HK) PT Raised to HK$55 at Goldman SachsGoldman Sachs raised its price target on Giant Biogene Holding Co (2367:HK) to HK$55.00 (from HK$48.00) while maintaining a Buy rating.

Best Analysts Covering Giant Biogene Holding Co. Ltd.

Which Analyst Should I Follow If I Want to Buy HK:2367 and Sell After:
1 Month
xxx
Success Rate
1/2 ratings generated profit
50%
Average Return
+3.15%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +3.15% per trade.
3 Months
xxx
Success Rate
2/2 ratings generated profit
100%
Average Return
+12.45%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +12.45% per trade.
1 Year
Jill WuCMB International Securities
Success Rate
2/2 ratings generated profit
100%
Average Return
+40.55%
reiterated a buy rating 4 months ago
Copying Jill Wu's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +40.55% per trade.
2 Years
xxx
Success Rate
2/2 ratings generated profit
100%
Average Return
+39.20%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +39.20% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

2367 Analyst Recommendation Trends

Rating
May 24
Jun 24
Aug 24
Sep 24
Oct 24
Strong Buy
0
0
1
1
2
Buy
4
4
2
2
2
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
4
3
3
4
In the current month, 2367 has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 2367 average Analyst price target in the past 3 months is HK$70.07.
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

2367 Financial Forecast

2367 Earnings Forecast

Next quarter’s earnings estimate for 2367 is HK$1.06 with a range of HK$1.06 to HK$1.06. The previous quarter’s EPS was HK$1.03. 2367 beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 38.51% of the time in the same period. In the last calendar year 2367 has Outperformed its overall industry.
Next quarter’s earnings estimate for 2367 is HK$1.06 with a range of HK$1.06 to HK$1.06. The previous quarter’s EPS was HK$1.03. 2367 beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 38.51% of the time in the same period. In the last calendar year 2367 has Outperformed its overall industry.

2367 Sales Forecast

Next quarter’s sales forecast for 2367 is HK$2.73B with a range of HK$2.73B to HK$2.73B. The previous quarter’s sales results were HK$2.75B. 2367 beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 53.85% of the time in the same period. In the last calendar year 2367 has Outperformed its overall industry.
Next quarter’s sales forecast for 2367 is HK$2.73B with a range of HK$2.73B to HK$2.73B. The previous quarter’s sales results were HK$2.75B. 2367 beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 53.85% of the time in the same period. In the last calendar year 2367 has Outperformed its overall industry.

2367 Stock Forecast FAQ

What is HK:2367’s average 12-month price target, according to analysts?
Based on analyst ratings, Giant Biogene Holding Co. Ltd.’s 12-month average price target is HK$70.07.
    What is HK:2367’s upside potential, based on the analysts’ average price target?
    Giant Biogene Holding Co. Ltd. has 34.75% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Giant Biogene Holding Co. Ltd. a Buy, Sell or Hold?
          Giant Biogene Holding Co. Ltd. has a consensus rating of Strong Buy, which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Giant Biogene Holding Co. Ltd.’s share price target?
            The average share price target for Giant Biogene Holding Co. Ltd. is HK$70.07. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is HK$80.00 ,and the lowest forecast is HK$65.00. The average share price target represents 34.75% Increase from the current price of HK$52.
              What do analysts say about Giant Biogene Holding Co. Ltd.?
              Giant Biogene Holding Co. Ltd.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
                How can I buy shares of Giant Biogene Holding Co. Ltd.?
                To buy shares of HK:2367, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis